(Q35824086)

English

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

scientific article published in January 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus (English)

1 reference

Europe PubMed Central

10 August 2017

type 2 diabetes

0 references

Jens Juul Holst

4

object named as

Holst JJ

1 reference

Europe PubMed Central

10 August 2017

author name string

Nauck MA

1

1 reference

Europe PubMed Central

10 August 2017

Heimesaat MM

2

1 reference

Europe PubMed Central

10 August 2017

Orskov C

3

1 reference

Europe PubMed Central

10 August 2017

Ebert R

5

1 reference

Europe PubMed Central

10 August 2017

Creutzfeldt W

6

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

1 January 1993

1 reference

Europe PubMed Central

10 August 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

10 August 2017

91

1 reference

Europe PubMed Central

10 August 2017

301-307

1 reference

Europe PubMed Central

10 August 2017

1

1 reference

Europe PubMed Central

10 August 2017

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

The isolation and sequencing of human gastric inhibitory peptide (GIP)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Radioimmunoassay for Gastric Inhibitory Polypeptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Immunoreactive gastric inhibitory polypeptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Complete sequences of glucagon-like peptide-1 from human and pig small intestine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) im man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

The incretin concept today

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=330027

11 July 2018

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin effect due to increased secretion and decreased clearance of insulin in normal humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glucagon-like peptide-1 on insulin secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagonlike peptide I (7-37) actions on endocrine pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of insulin secretion by gastric inhibitory polypeptide in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disturbances of the entero-insular axis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423228

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI116186

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35824086&oldid=1523208689"